Cigna Corporation

General ticker "CI" information:

  • Sector: Health Care
  • Industry: Health Care Providers & Services
  • Capitalization: $91.3B (TTM average)

Cigna Corporation does not follow the US Stock Market performance with the rate: -25.9%.

Estimated limits based on current volatility of 1.6%: low 321.84$, high 332.57$

Factors to consider:

  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2025-03-05, amount 1.51$ (Y1.91%)
  • US accounted for 98.1% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [215.49$, 328.38$]
  • 2025-12-31 to 2026-12-31 estimated range: [204.87$, 314.87$]

Financial Metrics affecting the CI estimates:

  • Positive: Non-GAAP EPS, $ of 27.34 > 2.19
  • Positive: 22.52 < Shareholder equity ratio, % of 26.32 <= 43.26
  • Positive: -1.21 < Return on assets ratio (scaled to [-100,100]) of 0.22
  • Negative: Investing cash flow per share, $ of -7.47 <= -3.20
  • Positive: 7.09 < Operating cash flow per share per price, % of 12.16
  • Negative: -0.28 < Industry inventory ratio change (median), % of 0
  • Negative: Interest expense per share, $ of 5.10 > 0.67

Similar symbols

Short-term CI quotes

2025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-012025-05-022025-05-052025-05-062025-05-072025-05-082025-05-092025-05-12310315320325330335340345350
Price $

Long-term CI plot with estimates

200250300350400Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 20270246
CIS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $180,516.00MM $195,187.00MM $244,384.00MM
Operating Expenses $172,102.00MM $186,651.00MM $239,115.00MM
Operating Income $8,414.00MM $8,536.00MM $5,269.00MM
Non-Operating Income $-61.00MM $-3,023.00MM $0.00MM
Interest Expense $0.00MM $1,446.00MM $1,435.00MM
Income(Loss) $8,353.00MM $5,513.00MM $5,269.00MM
Taxes $1,607.00MM $141.00MM $1,491.00MM
Profit(Loss)* $6,782.00MM $5,164.00MM $3,434.00MM
Stockholders Equity $44,675.00MM $46,223.00MM $41,033.00MM
Inventory $4,777.00MM $0.00MM $6,692.00MM
Assets $143,885.00MM $152,761.00MM $155,881.00MM
Operating Cash Flow $8,656.00MM $11,813.00MM $10,363.00MM
Capital expenditure $1,295.00MM $1,573.00MM $1,406.00MM
Investing Cash Flow $3,098.00MM $-5,174.00MM $-2,102.00MM
Financing Cash Flow $-11,240.00MM $-4,294.00MM $-7,647.00MM
Earnings Per Share** $21.66 $17.57 $12.25

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.